⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Nutricosmetics Market Poised for Strong Growth as Beauty Trends, Preventive Healthcare Focus, and Ingredient Innovation Accelerate Adoption: Verified Market Research®
prnewswire.com
PFE
GSK
A Decade of 18.65% CAGR Growth Ahead for AI in Regulatory Affairs Ecosystems
globenewswire.com
PFE
SNY
NVS
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
businesswire.com
PFE
GSK
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
businesswire.com
PFE
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
businesswire.com
PFE
Life Science Precision Parts Research Report 2025: A $13.92 Billion Market by 2030 Featuring Key Players - Gemsons, Arc, Precision Resource, Thermo Fisher Scientific, Stryker, Linamar, TS Prototypes
globenewswire.com
TMO
ILMN
PFE
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
prnewswire.com
AMGN
CNTB
NKTR
APGE
LLY
OGN
ABBV
PFE
REGN
INCY
Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer
prnewswire.com
JNJ
PFE